Patients with multiple myeloma frequently present with substantial immune impairment and
an increased risk for infections and infection-related mortality. The risk for infection with SARS…

The European Myeloma Network (EMN) organized two flow cytometry workshops. The first
aimed to identify specific indications for flow cytometry in patients with monoclonal …

… a, Cycling duration to a short circuit as a function of current density in Zn|Ti cells with 3 M
ZnSO 4 electrolyte at the same capacity per cycle (1 mAh cm –2 ), the ‘+’ signs above the 10 …

Background Selinexor, a selective inhibitor of nuclear export compound that blocks exportin
1 (XPO1) and forces nuclear accumulation and activation of tumor suppressor proteins, …

OBJECTIVES: The first consensus report presented by the European Germ Cell Cancer
Consensus Group (EGCCCG) in the year 2004 has found widespread approval by many …

Rationale: Impaired vascular reactivity is an important factor in the pathogenesis of cardiovascular
disease. Objectives: We sought to assess vascular reactivity in patients with chronic …

Chemokine receptor 4 (CXCR4) is a key factor for tumor growth and metastasis in several
types of human cancer. Based on promising experiences with a radiolabeled CXCR4 ligand ( …

… In our cohort, CXCR4-positivity was independent from myeloma subtype, M protein and free
serum light chain levels or presence of high-risk cytogenetics. Of note, CXCR4 expression of …

SLAMF7 is under intense investigation as a target for immunotherapy in multiple myeloma.
In this study, we redirected the specificity of T cells to SLAMF7 through expression of a …

… H929 cells were transfected for short periods of time (1 d) with IRF4 siRNA, the percentage
of cells in the G0/G1 phase increased, whereas the percentage of cells in S phase and G2/M …